Maintain or increase your exercise routine
Ready to explore your personalized weight loss program options at GobyMeds
Weeks 1-4: 0.25mg weekly subcutaneous injection Weeks 5-8: 0.5mg weekly subcutaneous injection Weeks 9-12: 1.0mg weekly subcutaneous injection Weeks 13+: 1.0mg maintenance or increase to 1.7-2.4mg based on response The starting dose of 0.25mg per week produces minimal appetite suppression but allows gastrointestinal adaptation
Rotate injection sites each time to reduce irritation
Is Retatrutide (LY3437943), a GLP-1, GIP, and Glucagon Receptor Agonist a Step Forward in the Treatment of Diabetes and Obesity
Its a potentially serious condition that can contribute to high blood pressure, fatigue and heart problems, among other negative health outcomes. But since she started taking semaglutide, Martin has lost 16% of her body weight and says she feels better than ever